Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
10306 | 1075 | 43.9 | 76% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
133 | 3 | MELATONIN//SLEEP//JOURNAL OF PINEAL RESEARCH | 66554 |
454 | 2 | MELATONIN//JOURNAL OF PINEAL RESEARCH//PINEAL GLAND | 16071 |
10306 | 1 | MELATONIN//LIGHT AT NIGHT//JOURNAL OF PINEAL RESEARCH | 1075 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MELATONIN | authKW | 949227 | 52% | 6% | 563 |
2 | LIGHT AT NIGHT | authKW | 359117 | 3% | 41% | 31 |
3 | JOURNAL OF PINEAL RESEARCH | journal | 331686 | 16% | 7% | 167 |
4 | CHRONONEUROENDOCRINE ONCOL | address | 312438 | 1% | 100% | 11 |
5 | CIRCADIAN DISRUPTION | authKW | 299912 | 3% | 34% | 31 |
6 | EXPT NEUROENDOCRINOL ONCOL | address | 181779 | 1% | 80% | 8 |
7 | MT1 RECEPTOR | authKW | 146484 | 1% | 37% | 14 |
8 | STRUCT CELLULAR BIOL | address | 103518 | 3% | 11% | 34 |
9 | NIGHT SHIFT WORK | authKW | 101199 | 1% | 25% | 14 |
10 | PINEAL EXTRACTS | authKW | 85210 | 0% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 5104 | 27% | 0% | 291 |
2 | Oncology | 4743 | 35% | 0% | 377 |
3 | Physiology | 3400 | 20% | 0% | 214 |
4 | Neurosciences | 1607 | 24% | 0% | 259 |
5 | Public, Environmental & Occupational Health | 704 | 12% | 0% | 125 |
6 | Medicine, Research & Experimental | 380 | 8% | 0% | 87 |
7 | Biology | 81 | 3% | 0% | 34 |
8 | BIOLOGY, MISCELLANEOUS | 70 | 0% | 0% | 2 |
9 | Integrative & Complementary Medicine | 45 | 1% | 0% | 10 |
10 | Cell Biology | 35 | 5% | 0% | 55 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CHRONONEUROENDOCRINE ONCOL | 312438 | 1% | 100% | 11 |
2 | EXPT NEUROENDOCRINOL ONCOL | 181779 | 1% | 80% | 8 |
3 | STRUCT CELLULAR BIOL | 103518 | 3% | 11% | 34 |
4 | CARCINOGENESIS ONCOGERONTOL | 78637 | 1% | 23% | 12 |
5 | TULANE CIRCADIAN BIOL | 63906 | 0% | 75% | 3 |
6 | ISRAELI INTERDISCIPLINARY CHRONOBIOL | 63253 | 1% | 32% | 7 |
7 | EXPT ENDOCRINOL HORMONE DIAGNOST | 60530 | 1% | 24% | 9 |
8 | TULANE CANC | 60318 | 3% | 8% | 27 |
9 | DEV HERBAL HLTH PROD CRD HHP | 56807 | 0% | 100% | 2 |
10 | WOMENS HOSP CLIN PHARMACOL SECT | 56807 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF PINEAL RESEARCH | 331686 | 16% | 7% | 167 |
2 | NEUROENDOCRINOLOGY LETTERS | 17547 | 4% | 1% | 42 |
3 | CHRONOBIOLOGY INTERNATIONAL | 5496 | 2% | 1% | 21 |
4 | INTEGRATIVE CANCER THERAPIES | 4919 | 1% | 2% | 9 |
5 | CANCER CAUSES & CONTROL | 4579 | 2% | 1% | 23 |
6 | CANCER LETTERS | 2669 | 3% | 0% | 34 |
7 | JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS | 2143 | 1% | 1% | 10 |
8 | SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH | 2063 | 1% | 1% | 14 |
9 | JOURNAL OF NEURAL TRANSMISSION | 1986 | 2% | 0% | 17 |
10 | CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 1774 | 2% | 0% | 20 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MELATONIN | 949227 | 52% | 6% | 563 | Search MELATONIN | Search MELATONIN |
2 | LIGHT AT NIGHT | 359117 | 3% | 41% | 31 | Search LIGHT+AT+NIGHT | Search LIGHT+AT+NIGHT |
3 | CIRCADIAN DISRUPTION | 299912 | 3% | 34% | 31 | Search CIRCADIAN+DISRUPTION | Search CIRCADIAN+DISRUPTION |
4 | MT1 RECEPTOR | 146484 | 1% | 37% | 14 | Search MT1+RECEPTOR | Search MT1+RECEPTOR |
5 | NIGHT SHIFT WORK | 101199 | 1% | 25% | 14 | Search NIGHT+SHIFT+WORK | Search NIGHT+SHIFT+WORK |
6 | PINEAL EXTRACTS | 85210 | 0% | 100% | 3 | Search PINEAL+EXTRACTS | Search PINEAL+EXTRACTS |
7 | PSYCHONCOLOGY | 71004 | 0% | 50% | 5 | Search PSYCHONCOLOGY | Search PSYCHONCOLOGY |
8 | PINEAL GLAND | 68216 | 5% | 4% | 59 | Search PINEAL+GLAND | Search PINEAL+GLAND |
9 | RZR ROR RECEPTORS | 63906 | 0% | 75% | 3 | Search RZR+ROR+RECEPTORS | Search RZR+ROR+RECEPTORS |
10 | CHRONODISRUPTION | 60582 | 1% | 27% | 8 | Search CHRONODISRUPTION | Search CHRONODISRUPTION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MEDIAVILLA, MD , SANCHEZ-BARCELO, EJ , TAN, DX , MANCHESTER, L , REITER, RJ , (2010) BASIC MECHANISMS INVOLVED IN THE ANTI-CANCER EFFECTS OF MELATONIN.CURRENT MEDICINAL CHEMISTRY. VOL. 17. ISSUE 36. P. 4462-4481 | 125 | 63% | 90 |
2 | BIZZARRI, M , PROIETTI, S , CUCINA, A , REITER, RJ , (2013) MOLECULAR MECHANISMS OF THE PRO-APOPTOTIC ACTIONS OF MELATONIN IN CANCER: A REVIEW.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 17. ISSUE 12. P. 1483-1496 | 80 | 63% | 25 |
3 | PROIETTI, S , CUCINA, A , REITER, RJ , BIZZARRI, M , (2013) MOLECULAR MECHANISMS OF MELATONIN'S INHIBITORY ACTIONS ON BREAST CANCERS.CELLULAR AND MOLECULAR LIFE SCIENCES. VOL. 70. ISSUE 12. P. 2139-2157 | 102 | 48% | 20 |
4 | NOOSHINFAR, E , SAFAROGHLI-AZAR, A , BASHASH, D , AKBARI, ME , (2017) MELATONIN, AN INHIBITORY AGENT IN BREAST CANCER.BREAST CANCER. VOL. 24. ISSUE 1. P. 42 -51 | 45 | 63% | 1 |
5 | VISTISEN, HT , GARDE, AH , FRYDENBERG, M , CHRISTIANSEN, P , HANSEN, AM , HANSEN, J , BONDE, JPE , KOLSTAD, HA , (2017) SHORT-TERM EFFECTS OF NIGHT SHIFT WORK ON BREAST CANCER RISK: A COHORT STUDY OF PAYROLL DATA.SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH. VOL. 43. ISSUE 1. P. 59 -67 | 34 | 71% | 1 |
6 | VISWANATHAN, AN , SCHERNHAMMER, ES , (2009) CIRCULATING MELATONIN AND THE RISK OF BREAST AND ENDOMETRIAL CANCER IN WOMEN.CANCER LETTERS. VOL. 281. ISSUE 1. P. 1 -7 | 54 | 75% | 65 |
7 | RONDANELLI, M , FALIVA, MA , PERNA, S , ANTONIELLO, N , (2013) UPDATE ON THE ROLE OF MELATONIN IN THE PREVENTION OF CANCER TUMORIGENESIS AND IN THE MANAGEMENT OF CANCER CORRELATES, SUCH AS SLEEP-WAKE AND MOOD DISTURBANCES: REVIEW AND REMARKS.AGING CLINICAL AND EXPERIMENTAL RESEARCH. VOL. 25. ISSUE 5. P. 499-510 | 66 | 56% | 12 |
8 | MA, ZQ , YANG, Y , FAN, CX , HAN, J , WANG, DJ , DI, SY , HU, W , LIU, D , LI, XF , REITER, RJ , ET AL (2016) MELATONIN AS A POTENTIAL ANTICARCINOGEN FOR NON-SMALL-CELL LUNG CANCER.ONCOTARGET. VOL. 7. ISSUE 29. P. 46768 -46784 | 73 | 48% | 0 |
9 | COS, S , SANCHEZ-BARCELO, EJ , (2000) MELATONIN AND MAMMARY PATHOLOGICAL GROWTH.FRONTIERS IN NEUROENDOCRINOLOGY. VOL. 21. ISSUE 2. P. 133 -170 | 78 | 58% | 118 |
10 | HILL, SM , BELANCIO, VP , DAUCHY, RT , XIANG, SL , BRIMER, S , MAO, LL , HAUCH, A , LUNDBERG, PW , SUMMERS, W , YUAN, L , ET AL (2015) MELATONIN: AN INHIBITOR OF BREAST CANCER.ENDOCRINE-RELATED CANCER. VOL. 22. ISSUE 3. P. R183 -R204 | 63 | 41% | 22 |
Classes with closest relation at Level 1 |